QLI
Get informed when a big investor buys or sells
+ FollowOvervalued by 92.1% based on the discounted cash flow analysis.
| Market cap | $73.23 Million |
|---|---|
| Enterprise Value | $69.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.22 |
| Beta | 1.41 |
| Outstanding Shares | 35,750,000 |
| P/E Ratio | -24.86 |
|---|---|
| PEG | 6.87 |
| Price to Sales | 2.71 |
| Price to Book Ratio | 1.08 |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | -8.25 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycl...